Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Recruiting · NCT06297096 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease | Skin and Connective Tissue Diseases, connective tissue disorder, interstitial lung disease, lung disorder, respiratory system disorder, skin disorder, systemic sclerosis | Recruiting | Phase 3 | 2026-04-08 | NCT06297096 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical Research Agency, Poland | 33 |
| National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centrum Wsparcia Badań Klinicznych | Warsaw | Poland | 3 |